Physician profile
Peter Tieh
NPI 1538486188
$1,142.98
in general payments reported to CMS, 2019-2025
25 companies · $91.17 in 2025
The $91.17 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276 · 2020: $235 · 2021: $197 · 2022: $74.28 · 2023: $145 · 2024: $124 · 2025: $91.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $360.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $128.60 | 2019-2021 | |
| Novo Nordisk INC | $105.20 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $103.48 | 2020-2021 | |
| Pfizer INC. | $90.50 | 2021-2025 | |
| Seqirus USA INC | $76.66 | 2023-2025 | Flucelvax, Flucelvax Quadrivalent |
| Endo Pharmaceuticals INC. | $64.03 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $60.06 | 2019-2022 | |
| Abbvie INC. | $59.08 | 2019-2020 | |
| Insulet Corporation | $53.38 | 2019-2022 | |
| Cranial Technologies, INC | $51.84 | 2022-2024 | Doc Band |
| Ascendis Pharma Endocrinology INC | $42.15 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $40.69 | 2019-2020 | |
| Sanofi Pasteur INC. | $38.52 | 2022-2023 | |
| Tandem Diabetes Care, INC. | $32.38 | 2019 | |
| Glaxosmithkline, LLC. | $28.85 | 2023 | Bexsero |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $23.27 | 2024 | |
| Xeris Pharmaceuticals, INC. | $22.45 | 2021 | |
| Phadia US INC. | $18.93 | 2025 | Immunocap |
| Photonicare INC | $18.27 | 2024 | Otosight Middle Ear Scope |
| Companion Medical, INC. | $15.80 | 2020 | |
| Medtronic Minimed, INC. | $15.32 | 2019 | |
| Lifescan, INC. | $14.48 | 2020 | |
| Merck Sharp & Dohme LLC | $13.49 | 2025 | Gardasil 9, Enflonsia, Vaxneuvance |
| Cumberland Pharmaceuticals, INC. | $13.41 | 2023 | Kristalose |
| Ferring Pharmaceuticals INC. | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Tieh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.